Long-term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade

被引:0
作者
Uchida, Tsuyoshi [1 ,2 ]
Matsubara, Hirochika [1 ]
Muto, Mamoru [1 ]
Sasanuma, Harunobu [1 ]
Sugimura, Saya [1 ]
Onuki, Yuichiro [1 ]
Nakajima, Hiroyuki [1 ]
机构
[1] Univ Yamanashi, Dept Thorac Surg, Chuo, Japan
[2] Yamanashi Univ, Dept Thorac Surg, 1110 Shimokato, Chuo, Yamanashi 4003898, Japan
来源
CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期
关键词
cardiac tamponade; immunotherapy; non-small cell lung cancer; pembrolizumab; radiotherapy;
D O I
10.1002/ccr3.6795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 69-year-old man with non-small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long-term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when complicated by cardiac tamponade.
引用
收藏
页数:4
相关论文
共 6 条
  • [1] Outcomes of patients with disease recurrence after treatment for locally advanced non-small cell lung cancer detected by routine follow-up CT scans versus a symptom driven evaluation
    Bodor, J. Nicholas
    Feliciano, Josephine L.
    Edelman, Martin J.
    [J]. LUNG CANCER, 2019, 135 : 16 - 20
  • [2] Five-Year Overall Survival for Patients With Advanced Non-Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
    Garon, Edward B.
    Hellmann, Matthew D.
    Rizvi, Naiyer A.
    Carcereny, Enric
    Leighl, Natasha B.
    Ahn, Myung-Ju
    Eder, Joseph Paul
    Balmanoukian, Ani S.
    Aggarwal, Charu
    Horn, Leora
    Patnaik, Amita
    Gubens, Matthew
    Ramalingam, Suresh S.
    Felip, Enriqueta
    Goldman, Jonathan W.
    Scalzo, Cathie
    Jensen, Erin
    Kush, Debra A.
    Hui, Rina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (28) : 2518 - +
  • [3] The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
    Goldstraw, Peter
    Chansky, Kari
    Crowley, John
    Rami-Porta, Ramon
    Asamura, Hisao
    Eberhardt, Wilfried E. E.
    Nicholson, Andrew G.
    Groome, Patti
    Mitchell, Alan
    Bolejack, Vanessa
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (01) : 39 - 51
  • [4] Pericardial diseases in patients with cancer: contemporary prevalence, management and outcomes
    Imazio, Massimo
    Colopi, Marzia
    De Ferrari, Gaetano Maria
    [J]. HEART, 2020, 106 (08) : 569 - 574
  • [5] Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
    Middleton, Gary
    Brock, Kristian
    Savage, Joshua
    Mant, Rhys
    Summers, Yvonne
    Connibear, John
    Shah, Riyaz
    Ottensmeier, Christian
    Shaw, Paul
    Lee, Siow-Ming
    Popat, Sanjay
    Barrie, Colin
    Barone, Gloria
    Billingham, Lucinda
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (09) : 895 - 904
  • [6] Lung Cancer Statistics
    Torre, Lindsey A.
    Siegel, Rebecca L.
    Jemal, Ahmedin
    [J]. LUNG CANCER AND PERSONALIZED MEDICINE: CURRENT KNOWLEDGE AND THERAPIES, 2016, 893 : 1 - 19